Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy

Allen, 1991, The role of the erythrocyte C3b (CR1) receptor in the pathogenesis of pre-eclampsia, Transfusion Med., 1, 62 Coyne, 1992, Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor, J. Immunol., 149, 2906, 10.4049/jimmunol.149.9.2906 Dorval, 1989, Human erythrocytes inhibit complement-mediated solubilization of immune complexes, J. Immunol., 142, 2721, 10.4049/jimmunol.142.8.2721 Gerdes, 1982, Human complement (C3b) receptors defined by a mouse monoclonal antibody, Immunology, 45, 645 Haeger, 1991, Complement activation in relation to development of pre-eclampsia, Obstet. Gynecol., 78, 46 Haeger, 1992, Complement, neutrophil and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes and low platelet count, Obstet. Gynecol., 79, 19 Heptinstall, 1993, Factors that potentiate or inhibit platelet activation by streptokinase, Thromb. Haemostasis, 69, 1074 Hogg, 1984, Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1), Eur. J. Immunol., 14, 236, 10.1002/eji.1830140307 Hopkinson, 1992, Classical complement activation induced by pregnancy: implications for management of connective tissue diseases, J. Clin. Pathol., 45, 66, 10.1136/jcp.45.1.66 Horn, 1991, Platelets in normal and hypertensive pregnancy, Platelets, 2, 183, 10.3109/09537109109005509 Jain, 1991, Circulating immune complexes in pre-eclampsia, J. Indian Med. Assoc., 89, 251 Jones, 1994, An enzyme-linked immunosorbent assay for complement regulatory proteins and membrane-bound immunoglobulins on intact red blood cells, J. Immunol. Methods, 177, 235, 10.1016/0022-1759(94)90161-9 Liu, 1987, Circulating immune complexes in preeclampsia and normal pregnancy, Chin. Med. J., 39, 317 Miyakawa, 1981, Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus, Lancet, ii, 493, 10.1016/S0140-6736(81)90882-5 Nicholson-Weller, 1994, Structure and function of decay accelerating factor CD55, J. Lab. Clin. Med., 485 Paccaud, 1991, Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1), Clin. Exp. Immunol., 84, 9 Pascual, 1994, Proteolytic cleavage of CR1 on human erythrocytes in vivo: Evidence for enhanced cleavage in AIDS, Eur. J. Immunol., 24, 702, 10.1002/eji.1830240332 Redman, 1992, Immunological aspects of pre-eclampsia, Baillière's Clin. Obstet. Gynaecol., 6, 601, 10.1016/S0950-3552(05)80012-4 Reincke, 1986, Examinations for evidence of circulating immune complexes in serum during normal pregnancy and in pregnancy-induced hypertension (PIH) by precipitation with polyethylene glycol, Z. Gynäkol., 108, 238 Siegel, 1981, The red-cell immune system, Lancet, ii, 556, 10.1016/S0140-6736(81)90941-7 Telen, 1991, Phosphatidylinositol-glycan linked proteins of the erythrocyte membrane, 849